PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 93 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,491,480 | -23.1% | 54,000 | -34.0% | 0.05% | -38.6% |
| Q1 2022 | $1,939,000 | -56.6% | 81,873 | -37.3% | 0.09% | -64.2% |
| Q4 2021 | $4,464,000 | +397.7% | 130,517 | +553.0% | 0.25% | +602.9% |
| Q2 2021 | $897,000 | -30.1% | 19,986 | -59.7% | 0.04% | -14.6% |
| Q1 2021 | $1,284,000 | +66.1% | 49,579 | +29.3% | 0.04% | +5.1% |
| Q4 2020 | $773,000 | +70.3% | 38,341 | +65.1% | 0.04% | +25.8% |
| Q3 2020 | $454,000 | -47.9% | 23,216 | -53.0% | 0.03% | -42.6% |
| Q2 2020 | $872,000 | – | 49,359 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |